Eur Rev Med Pharmacol Sci 2018; 22 (15): 4987-4994
DOI: 10.26355/eurrev_201808_15639

Combining clinical predictors to better predict for the no-reflow phenomenon

E. Avci, T. Yildirim, G. Aydin, T. Kiris, A. Dolapoglu, H. Kadi, O. Safak, S. Bayata

Cardiology Department, Balikesir University, Faculty of Medicine, Balikesir, Turkey. dreyupavci@gmail.com


OBJECTIVE: We aimed to determine whether the combination of a CHA2DS2-VASc score (C: Congestive Heart Failure, H: Hypertension, A2: Age ≥ 75 years, D: Diabetes mellitus, S: Stroke history, V: Vascular disease, A: Age ≥ 65 years, Sc: Sex category) and pre-percutaneous coronary intervention (PCI) thrombus load score was more sensitive at detecting the no-reflow phenomenon compared to the CHA2DS2-VASc score alone or to the thrombus load score alone in patients with acute ST-elevation myocardial infarction (STEMI) who had underwent primary PCI (PPCI).

PATIENTS AND METHODS: 497 patients with acute STEMIs were divided into two groups: no-reflow group (n: 194) and control group (n: 303). The Thrombolysis In Myocardial Infarction (TIMI) flow grading and Myocardial Blush Grade (MBG) were used together to define angiographic no-reflow as TIMI flow < 3 (with any MBG grade) or TIMI flow 3 with MBG 0 or 1. Successful reperfusion was defined as TIMI flow 3 with MBG 2 or 3.

RESULTS: CHA2DS2-VASc score was significantly higher in the no-reflow group than in the control group (2 [1-4] vs. 1 [0-3], p < 0.001]. Compared with the control group, the no-reflow group had a higher pre-PCI thrombus score (5 [4-5] vs. 4 [3-5], p = 0.001). Compared with the CHA2DS2-VASc score alone, the combined use of the pre-PCI thrombus score and the CHA2DS2-VASc score was associated with significant improvements in the ability to predict no-reflow (AUC) (0.65 vs. 0.60, p < 0.05). The addition of the pre-PCI thrombus score to the CHA2DS2-VASc score was related to a significant net reclassification improvement of 6.7% (p = 0.047) and an integrated discrimination improvement of 0.036 (p < 0.05).

CONCLUSIONS: We have found that the combination of a CHA2DS2-VASc score and a pre-PCI thrombus load score was more sensitive in detecting the no-reflow phenomenon than only a CHA2DS2-VASc score in patients who underwent PPCIs for STEMIs.

Free PDF Download

To cite this article

E. Avci, T. Yildirim, G. Aydin, T. Kiris, A. Dolapoglu, H. Kadi, O. Safak, S. Bayata
Combining clinical predictors to better predict for the no-reflow phenomenon

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 15
Pages: 4987-4994
DOI: 10.26355/eurrev_201808_15639